Familial cancer with pathogenic germline alterations (BRCA1, BRCA2, ATM, PALB2, MLH1, MSH2, MSH6, PMS2, CDKN2A, P53 and others still unknown), which involves 10% of the whole PDAC patients, is the only established high-risk population. This evidence concerns the gene CDKN2A and cancer.